首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia,myelodysplastic syndrome,or acute myeloid leukemia with transfusional iron overload
Authors:Sung‐Nam Lim  Sang‐Kyun Sohn  Hoon‐Gu Kim  Gyeong‐Won Lee  Yang‐Soo Kim  Ho‐Sup Lee  Ki‐Young Kwon  Sung‐Hyun Kim  Kyung‐Tae Park  Joo‐Seop Chung  Won‐Sik Lee  Sang‐Min Lee  Myung‐Soo Hyun  Hawk Kim  Hun‐Mo Ryoo  Sung‐Hwa Bae  Young‐Don Joo
Affiliation:1. Department of Hemato‐Oncology, Inje University Haeundae Paik Hospital, Busan;2. Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu;3. Department of Hematology/Oncology, Gyeongsang National University Hospital, Jinju;4. Department of Hematology/Oncology, Kosin University College of Medicine, Busan;5. Department of Hematology/Oncology, Dongsan Medical Center, Daegu;6. Department of Hematology/Oncology, Dong‐a University Hospital, Busan;7. Department of Hematology/Oncology, Sungkyunkwan University Samsung Changwon Hospital, Changwon;8. Department of Hematology/Oncology, Pusan National University, Busan;9. Department of Hemato‐Oncology, Inje University Busan Paik Hospital, Busan;10. Department of Hematology/Oncology, Yeungnam University Medical Center, Daegu;11. Division of Hematology, Ulsan University Hospital, Ulsan;12. Department of Hematology/Oncology, Daegu Catholic University Medical Center, Daegu, Korea
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号